← Back to Home

Gossamer Bio

NASDAQ: GOSS ↗$10.41 USDTBD MCAP

Gossamer Bio is a small molecule pharma company covered in the openbionews harvest.

Company Info

Sector:Small Molecule Pharma

Headquarters:TBD

Founded:2015

Website:www.gossamerbio.com/

Recent News

Business & Strategy•Jul 27, 2026•Fierce Biotech

Gossamer and Chiesi pull the plug on PAH drug collaboration ↗

Gossamer and Chiesi pull the plug on PAH drug collaboration.

Leadership Team

Careers & Job Openings

See all open roles

—

—